Stay updated on DETERMINE-preserved: Dapagliflozin Clinical Trial
Sign up to get notified when there's something new on the DETERMINE-preserved: Dapagliflozin Clinical Trial page.

Latest updates to the DETERMINE-preserved: Dapagliflozin Clinical Trial page
- Check7 days agoChange DetectedThe footer revision label changes from v3.7.1 to v3.7.2 while the page continues to display a 403 Forbidden error.SummaryDifference0.2%

- Check14 days agoChange DetectedThe footer revision label changed from v3.7.0 to v3.7.1.SummaryDifference0.2%

- Check21 days agoNo Change Detected
- Check35 days agoChange DetectedA new Revision: v3.7.0 tag appears. Several study documents and links were removed from the page, indicating a revision of the available materials rather than updates to core content.SummaryDifference17%

- Check56 days agoChange DetectedThe study page now includes the NIH grant/contract note under its identifiers, and the page revision was updated from v3.6.5 to v3.6.6.SummaryDifference0.1%

- Check77 days agoChange DetectedRevision updated from v3.6.4 to v3.6.5. This change reflects a minor maintenance update to the page's revision metadata and does not alter the study information presented.SummaryDifference0.0%

- Check92 days agoChange DetectedFooter text updated to Revision: v3.6.4, replacing the previous Revision: v3.6.3. This indicates a minor maintenance update and does not alter study details or functionality.SummaryDifference0.0%

Stay in the know with updates to DETERMINE-preserved: Dapagliflozin Clinical Trial
Enter your email address, and we'll notify you when there's something new on the DETERMINE-preserved: Dapagliflozin Clinical Trial page.